Crossmark

Evolocumab administration prior to Coronary Artery Bypass Grafting in patients with multivessel coronary artery disease (EVOCABG): study protocol for a randomized controlled clinical trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06398-3

Published Online: 2022-05-23

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Na, Hye Rim

Kwon, O Sung

Kang, Joon Kyu

Kim, Yong Han

Lim, Ju Yong https://orcid.org/0000-0002-2864-1630
License Information

Text and Data Mining valid from 2022-05-23

Version of Record valid from 2022-05-23
More Information

Article History

Received: 29 December 2021

Accepted: 11 May 2022

First Online: 23 May 2022

Declarations

:

: Ethical approval was obtained from the IRB of Seoul St. Mary’s Hospital (KC20MIDT0760). Informed consent will be provided to all participating subjects.

: No consent was needed due to exclusion of any personal information.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below